Merck's Latest Move: Why the Verona Deal Still Leaves Questions
14/7 09:56
Merck’s latest acquisition announcement sends a clear message about its urgency to address the looming Keytruda patent cliff. The pharmaceutical giant has agreed to purchase COPD drugmaker Verona Pharma for $10 billion, adding another potential blockbuster to its growing po...